AIM
Alerce Investment Management Portfolio holdings
AUM
$56.8M
This Quarter Return
-31.17%
1 Year Return
+31.17%
3 Year Return
+25.12%
5 Year Return
–
10 Year Return
–
AUM
$98.3M
AUM Growth
+$98.3M
(-33%)
Cap. Flow
+$0
Cap. Flow
% of AUM
0%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
7
New
–
Increased
–
Reduced
–
Closed
–
Top Buys
No buys this quarter
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
American Well
AMWL
$111M
| $38.1M | 38.71% | 6,300,773 | – | – |
|
2
Annexon
ANNX
$226M
| $22.5M | 22.85% | 1,954,978 | – | – |
|
3
Akebia Therapeutics
AKBA
$833M
| $10.5M | 10.69% | 4,652,561 | – | – |
|
|
RNTX
4
Rein Therapeutics, Inc. Common Stock
RNTX
$32M
| $9.35M | 9.51% | 16,609,449 | – | – |
|
|
WHWK
5
Whitehawk Therapeutics, Inc. Common Stock
WHWK
$84.8M
| $9.05M | 9.21% | 374,785 | – | – |
|
6
Assembly Biosciences
ASMB
$190M
| $5.19M | 5.28% | 2,227,500 | – | – |
|
|
GBT
7
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $3.7M | 3.76% | 126,270 | – | – |
|